KIAA1467 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.867600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.582400E-01
Normal-vs-Stage2
9.187400E-01
Normal-vs-Stage3
1.203810E-01
Normal-vs-Stage4
4.841000E-01
Stage1-vs-Stage2
3.337000E-01
Stage1-vs-Stage3
2.075400E-01
Stage1-vs-Stage4
4.663800E-01
Stage2-vs-Stage3
3.831000E-01
Stage2-vs-Stage4
5.617200E-01
Stage3-vs-Stage4
6.087800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.824000E-01
Normal-vs-AfricanAmerican
8.599000E-01
Normal-vs-Asian
1.252010E-01
Caucasian-vs-AfricanAmerican
8.876600E-01
Caucasian-vs-Asian
2.082100E-03
AfricanAmerican-vs-Asian
5.952400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.465600E-01
Normal-vs-Female
9.229400E-01
Male-vs-Female
6.388000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.435400E-01
Normal-vs-Age(41-60Yrs)
8.385800E-02
Normal-vs-Age(61-80Yrs)
8.969600E-01
Normal-vs-Age(81-100Yrs)
6.045800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.025400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.268800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.979600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.995800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.958200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.128600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.222000E-01
Normal-vs-Daily Drinker
6.667000E-01
Normal-vs-Weekly Drinker
2.513200E-01
Normal-vs-Occasional Drinker
1.579040E-01
Normal-vs-Social Drinker
5.009800E-01
Non Drinker-vs-Daily Drinker
2.459400E-01
Non Drinker-vs-Weekly Drinker
7.170800E-01
Non Drinker-vs-Occasional Drinker
5.213900E-02
Non Drinker-vs-Social Drinker
1.558980E-01
Daily Drinker-vs-Weekly Drinker
1.910580E-01
Daily Drinker-vs-Occasional Drinker
3.609600E-01
Daily Drinker-vs-Social Drinker
8.760800E-01
Weekly Drinker-vs-Occasional Drinker
4.069600E-02
Weekly Drinker-vs-Social Drinker
1.175170E-01
Occasional Drinker-vs-Social Drinker
4.514000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.701200E-01
Normal-vs-Grade 2
5.018800E-01
Normal-vs-Grade 3
3.890800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.821800E-02
Grade 1-vs-Grade 3
9.556400E-02
Grade 1-vs-Grade 4
4.701200E-01
Grade 2-vs-Grade 3
4.969600E-01
Grade 2-vs-Grade 4
5.018800E-01
Grade 3-vs-Grade 4
3.890800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.101400E-01
Normal-vs-NonDiabetic
8.752800E-01
Diabetic-vs-NonDiabetic
8.196800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.683000E-01
Normal-vs-NoPancreatitis
8.870600E-01
Pancreatitis-vs-NoPancreatitis
4.747600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.276600E-01
Normal-vs-N1
9.853600E-01
N0-vs-N1
6.990800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.794600E-01
Normal-vs-TP53-NonMutant
9.911600E-02
TP53-Mutant-vs-TP53-NonMutant
3.930500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
